“…Currently, the following questions on MRSA surveillance and decolonization in neonates are yet to be addressed: (1) the implementation of universal versus targeted active surveillance cultures in neonates at high risk for MRSA colonization and infection [10, 64], (2) the definition of optimum surveillance time points to better identify colonized neonates [10, 64], and (3) the benefit of screening extranasal sites for early identification of colonized infants [10, 16, 64]. Moreover, the importance of new screening methods, such as polymerase chain reaction and whole-genome sequencing, needs to be defined [6, 7, 10, 16, 64]. Since MRSA resistant to mupirocin and antiseptics have been reported [18, 44, 71], the efficacy of nasal mupirocin application in primary and persistent MRSA decolonization warrants verification [10, 70, 72], Finally, potential adverse effects of antiseptic baths, such as skin irritation and toxicity [73], as well as nonantimicrobial strategies like maternal skin-to-skin contact for MRSA decolonization remain subjects of discussion [74].…”